Literature DB >> 2545909

A major transcriptional regulatory protein (ICP4) of herpes simplex virus type 1 is associated with purified virions.

F Yao1, R J Courtney.   

Abstract

Herpes simplex virus type 1 was purified by density gradient centrifugation, and the virion-associated proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. By Western blot (immunoblot) analysis with an anti-ICP4 monospecific serum, the results indicated that ICP4, one of the five immediate-early proteins of herpes simplex virus type 1, was associated with the purified virions. To define the location of ICP4 within the virion, trypsin digestion experiments were performed. Purified virions were treated with trypsin in the presence or absence of detergent. The virus envelope appeared to protect ICP4 from the trypsin, since virus-associated ICP4 was sensitive to digestion only after detergent treatment. In addition, ICP4 remained associated with the virus particle when the virion-specific glycoproteins were removed after detergent treatment. Finally, ICP4 was not detected in purified preparations of type A and B capsids isolated from the nuclear fraction of virus-infected cells. The above-mentioned data suggest that detectable amounts of ICP4 are present within the tegument region of the virion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545909      PMCID: PMC250907          DOI: 10.1128/JVI.63.8.3338-3344.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells.

Authors:  K L Powell; R J Courtney
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

2.  Regulation of herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV-2 infected cells.

Authors:  L Pereira; M H Wolff; M Fenwick; B Roizman
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

3.  Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome.

Authors:  J B Clements; R J Watson; N M Wilkie
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

4.  Evidence of DNA: protein interactions that mediate HSV-1 immediate early gene activation by VP16.

Authors:  S J Triezenberg; K L LaMarco; S L McKnight
Journal:  Genes Dev       Date:  1988-06       Impact factor: 11.361

5.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

6.  A temperature-sensitive mutant of herpes simplex virus type 1 defective in the synthesis of the major capsid polypeptide.

Authors:  D R Bone; R J Courtney
Journal:  J Gen Virol       Date:  1974-07       Impact factor: 3.891

7.  Isolation and characterization of a large molecular-weight polypeptide of herpes simplex virus type 1.

Authors:  R J Courtney; M Benyesh-Melnick
Journal:  Virology       Date:  1974-12       Impact factor: 3.616

8.  Proteins specified by herpes simplex virus. VI. Viral proteins in the plasma membrane.

Authors:  J W Heine; P G Spear; B Roizman
Journal:  J Virol       Date:  1972-03       Impact factor: 5.103

9.  Comparison of the virion proteins specified by herpes simplex virus types 1 and 2.

Authors:  E N Cassai; M Sarmiento; P G Spear
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

10.  Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.

Authors:  J W Heine; R W Honess; E Cassai; B Roizman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  38 in total

Review 1.  Herpesvirus assembly and egress.

Authors:  Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Posttranslational modification and subcellular localization of the p12 capsid protein of herpes simplex virus type 1.

Authors:  D S McNabb; R J Courtney
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  In rat dorsal root ganglion neurons, herpes simplex virus type 1 tegument forms in the cytoplasm of the cell body.

Authors:  Monica Miranda-Saksena; Ross A Boadle; Patricia Armati; Anthony L Cunningham
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1.

Authors:  F Yao; R J Courtney
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Recruitment of herpes simplex virus type 1 immediate-early protein ICP0 to the virus particle.

Authors:  Kevin Maringer; Gillian Elliott
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

6.  Deletion of the herpes simplex virus VP22-encoding gene (UL49) alters the expression, localization, and virion incorporation of ICP0.

Authors:  Gillian Elliott; Wali Hafezi; Alison Whiteley; Emmanuelle Bernard
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  A type-specific conformational epitope on the nucleocapsid of equid herpesvirus-1 and its use in diagnosis.

Authors:  A van de Moer; M Rice; C R Wilks
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway.

Authors:  Heidi J Zapata; Masako Nakatsugawa; Jennifer F Moffat
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Detection and intracellular localization of equine herpesvirus 1 IR1 and IR2 gene products by using monoclonal antibodies.

Authors:  G B Caughman; J B Lewis; R H Smith; R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters.

Authors:  C L Wu; K W Wilcox
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.